Mon, Aug 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index Up 0.40% in November (+6.36% YTD)

Friday, December 14, 2012
Opalesque Industry Update: Hedge funds gained 0.40% in November, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 6.36% year to date.

“In spite of an early month sell-off driven by fiscal cliff fears followed by a mid-month rally fueled by encouraging economic data, hedge funds were able to get through the tumult with a small profit in November,” says Sol Waksman, founder and president of BarclayHedge.

The Barclay European Equities Index led all hedge fund strategies in November with a 1.54% gain. Merger Arbitrage was up 1.17%, the Event Driven Index added 0.83%, and Fixed Income Arbitrage gained 0.75%.

“Europe outperformed the US in November; the MSCI Europe Index gained 2.41 percent versus a gain of 0.58 percent for the S&P 500 Total Return Index,” says Waksman.

“In spite of the uncertainty of a clear path to resolution of the eurozone’s fiscal woes, European equities have managed to gain 12.8% this year.”

Only three of the 18 hedge fund strategies tracked by BarclayHedge had losses in November. The Equity Short Bias Index was down 2.34%, Technology lost 0.43%, and Global Macro slid 0.31%.

Year to date, Healthcare & Biotechnology is up 12.93%, and Distressed Securities have gained 10.00%, European Equities are up 8.55%, and Fixed Income Arbitrage has gained 8.47%.

Equity Short Bias is the only losing hedge fund strategy in 2012. After 11 months, Short Bias is down 19.34%. This is its biggest loss since 2003, when the Index was down 23.95% at year-end.

“Upward trending equity markets in 2012 have dealt short sellers a difficult hand to play this year,” says Waksman.

“The dramatic 10.04 percent jump in the Equity Short Bias Index in May was not enough to offset seven months of significant losses.”

The Barclay Fund of Funds Index gained 0.40% in November, and is up 3.40% in 2012.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: Despite bumpy June/July, CTAs hold on[more]

    Bailey McCann, Opalesque New York: To say that things have been rocky in managed futures recently is putting it mildly. In June, the industry saw its worst month on a performance basis in the past four years. Then yesterday,

  2. Other Voices: Same day reporting and the evolving role of fund administrators[more]

    By: Scott Price, Head of Business Development and Client Management for North America, Maitland Ernst & Young’s latest glob

  3. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  4. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  5. Cowen Group, Inc. to acquire Conifer Securities[more]

    Cowen Group, Inc. and Conifer Securities, LLC had announced the signing of a definitive agreement under which Cowen will acquire Conifer Securities, the prime services division of Conifer Financial Services LLC. The transaction, the terms of which have not yet been disclosed, was approved by the boa

 

banner